PrIME Biologics Private
Latest round
- Series A
Last raised
- May 2014
Total raised
- $13M
Investors
- 2
About PrIME Biologics Private
Founded in 2010 in Singapore, PrIME Biologics specializes in biological solutions for health applications.PrIME Biologics specializes in innovative biological solutions that cater to a diverse range of industries. The company’s core offerings focus on advanced biological products designed to address specific health and wellness needs. These products are developed through proprietary technologies that enhance their efficacy and usability in both clinical and everyday settings. The end-use cases include applications in regenerative medicine, therapeutic treatments, and enhanced biological functionalities. PrIME Biologics serves a broad client base that includes healthcare providers, research institutions, and end consumers across North America, Europe, and Asia. The company plans to introduce new biological products tailored for emerging healthcare needs, with launches anticipated by 2025. Targeted expansion includes entering additional markets in Asia and Europe, focusing specifically on regions that show demand for advanced therapeutic solutions.
Who invested in PrIME Biologics Private
2 investors across 1 round
See all investors in PrIME Biologics Private
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 9, 2014
Amount
$13M
Investors
Questions about PrIME Biologics Private
Who invested in PrIME Biologics Private?
PrIME Biologics Private has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PrIME Biologics Private raised?
PrIME Biologics Private has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did PrIME Biologics Private last raise money?
PrIME Biologics Private's most recent round on record is a Series A, in May 2014.
What does PrIME Biologics Private do?
Founded in 2010 in Singapore, PrIME Biologics specializes in biological solutions for health applications.
Where is PrIME Biologics Private headquartered?
PrIME Biologics Private is headquartered in Singapore, Singapore.
Which VCs invest in companies like PrIME Biologics Private?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biopolymers companies at PrIME Biologics Private's stage. Their profiles are linked below.
VCs backing biopolymers startups at Series A
Raising like PrIME Biologics Private? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.